{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T01:29:48Z","timestamp":1711157388696},"reference-count":0,"publisher":"International Scientific Information, Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci Monit"],"DOI":"10.12659\/msm.907876","type":"journal-article","created":{"date-parts":[[2018,4,29]],"date-time":"2018-04-29T19:12:26Z","timestamp":1525029146000},"page":"2302-2309","source":"Crossref","is-referenced-by-count":6,"title":["Anti-Interferon Alpha Antibodies in Patients with High-Risk BCR\/ABL-Negative Myeloproliferative Neoplasms Treated with Recombinant Human Interferon-\u03b1"],"prefix":"10.12659","volume":"24","author":[{"given":"Aruna","family":"Aruna","sequence":"first","affiliation":[{"name":", , South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limei","family":"Li","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Chongqing Medical University, Chongqing, China (mainland)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4947","published-online":{"date-parts":[[2018,4,17]]},"container-title":["Medical Science Monitor"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.medscimonit.com\/download\/index\/idArt\/907876","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,29]],"date-time":"2018-04-29T19:12:27Z","timestamp":1525029147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.medscimonit.com\/abstract\/index\/idArt\/907876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,17]]},"references-count":0,"alternative-id":["907876"],"URL":"https:\/\/doi.org\/10.12659\/msm.907876","relation":{},"ISSN":["1643-3750"],"issn-type":[{"value":"1643-3750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,17]]}}}